GlassScriptPhysician profile
Tea Nguyen
NPI 1811282494
$4,214.93
in general payments reported to CMS, 2019-2025
10 companies · $85.36 in 2025
The $85.36 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,136 · 2020: $132 · 2021: $1,290 · 2022: $28.76 · 2023: $394 · 2024: $149 · 2025: $85.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504 · Travel and Lodging: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.00 |
| Travel and Lodging | $124.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $2,308.98 | 2019-2021 | |
| Treace Medical Concepts, INC. | $747.57 | 2019 | |
| Smith+Nephew, INC. | $314.20 | 2019-2020 | |
| Organogenesis INC. | $256.69 | 2022-2023 | Puraply |
| Nevro Corp. | $166.03 | 2023 | Senza |
| Musculoskeletal Transplant Foundation INC. | $151.99 | 2020-2021 | |
| Alafair Biosciences, INC. | $149.20 | 2024 | Versawrap |
| Medtronic, INC. | $85.36 | 2025 | Venaseal |
| Osiris Therapeutics INC. | $19.60 | 2019 | |
| Axogen | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tea Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.